SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905718-14-000815
Filing Date
2014-12-19
Accepted
2014-12-19 16:03:49
Documents
2
Period of Report
2014-12-17

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT broek_form4dec192014.html 4  
1 OWNERSHIP DOCUMENT broek_form4dec192014.xml 4 5938
2 POWER OF ATTORNEY exhibit24.htm EX-24 5749
  Complete submission text file 0000905718-14-000815.txt   13285
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Issuer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 73 ARCH STREET 1ST FLOOR GREENWICH CT 06830
Business Address
van den Broek Richard (Reporting) CIK: 0001431872 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-15006 | Film No.: 141299591